g protein coupled receptor class c group 5 member d (Johnson & Johnson)
86
Structured Review
Johnson & Johnson
g protein coupled receptor class c group 5 member d
G Protein Coupled Receptor Class C Group 5 Member D, supplied by Johnson & Johnson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g+protein+coupled+receptor+class+c+group+5+member+d/5+c+class+coupled+d+g+group+member+protein+receptor/pm41565510-16-14-45
Average 86 stars, based on 1 article reviews
G Protein Coupled Receptor Class C Group 5 Member D, supplied by Johnson & Johnson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g+protein+coupled+receptor+class+c+group+5+member+d/5+c+class+coupled+d+g+group+member+protein+receptor/pm41565510-16-14-45
Average 86 stars, based on 1 article reviews
g protein coupled receptor class c group 5 member d - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Comparison:Article Title: Relative Effectiveness of Talquetamab Versus Real-World Physician's Choice Treatment Regimens in Patients With Relapsed/Refractory Multiple Myeloma: Updated Results From an Indirect Treatment Comparison. Article Snippet: The relative effectiveness of talquetamab was previously evaluated in indirect treatment comparisons of the MonumenTAL-1 trial and real-world treatment regimens from the Flatiron Health Research Database.. In this updated analysis, talquetamab demonstrated continued superiority over real-world treatment regimens, including in heavily pretreated patients.. These results suggest that talquetamab may improve survival over approved standard regimens in relapsed/refractory multiple myeloma. |